Package 71335-2375-3

{"route": ["ORAL"], "spl_id": "3b87a0c6-ec50-4d5a-b153-fcae02be4505", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897659"], "spl_set_id": ["f88dfe56-08bc-46b1-8f05-f886a16a89bc"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-2375-1)", "package_ndc": "71335-2375-1", "marketing_start_date": "20240708"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-2375-2)", "package_ndc": "71335-2375-2", "marketing_start_date": "20240708"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (71335-2375-3)", "package_ndc": "71335-2375-3", "marketing_start_date": "20240708"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-2375-4)", "package_ndc": "71335-2375-4", "marketing_start_date": "20240708"}, {"sample": false, "description": "10 TABLET in 1 BOTTLE (71335-2375-5)", "package_ndc": "71335-2375-5", "marketing_start_date": "20240708"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "71335-2375_3b87a0c6-ec50-4d5a-b153-fcae02be4505", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71335-2375", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "120 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20230102", "listing_expiration_date": "20261231"}